Innovations in genomics and big data analytics for personalized medicine and health care: A review

M Hassan, FM Awan, A Naz… - International journal of …, 2022 - mdpi.com
Big data in health care is a fast-growing field and a new paradigm that is transforming case-
based studies to large-scale, data-driven research. As big data is dependent on the …

The role of pharmacogenomics in adverse drug reactions

R Cacabelos, N Cacabelos, JC Carril - Expert Review of Clinical …, 2019 - Taylor & Francis
ABSTRACT Introduction: Adverse drug reactions (ADRs) are a major health concern
worldwide. There are multiple causes of ADRs, some of which are preventable …

Role of bioinformatics and pharmacogenomics in drug discovery and development process

P Katara - Network Modeling Analysis in Health Informatics and …, 2013 - Springer
Drug discovery and development is a complex, high risk, time consuming and potentially
highly rewarding process. Pharmaceutical companies literally burn millions of dollar per …

[HTML][HTML] Improving the translation of animal ischemic stroke studies to humans

GC Jickling, FR Sharp - Metabolic brain disease, 2015 - Springer
Despite testing more than 1,026 therapeutic strategies in models of ischemic stroke and 114
therapies in human ischemic stroke, only one agent tissue plasminogen activator has …

Pharmacogenomics in early-phase clinical development

T Burt, S Dhillon - Pharmacogenomics, 2013 - Taylor & Francis
Pharmacogenomics (PGx) offers the promise of utilizing genetic fingerprints to predict
individual responses to drugs in terms of safety, efficacy and pharmacokinetics. Early-phase …

Quality by design (QbD) approach of pharmacogenomics in drug designing and formulation development for optimization of drug delivery systems

S Gupta, V Jhawat - Journal of Controlled Release, 2017 - Elsevier
Conventional approaches of drug discovery are very complex, costly and time consuming.
But after the completion of human genome project, applications of pharmacogenomics in …

Pharmacogenetic testing: current evidence of clinical utility

J Moaddeb, SB Haga - Therapeutic advances in drug safety, 2013 - journals.sagepub.com
Over the last decade, the number of clinical pharmacogenetic tests has steadily increased
as understanding of the role of genes in drug response has grown. However, uptake of …

Pharmacogenomic knowledge representation, reasoning and genome-based clinical decision support based on OWL 2 DL ontologies

M Samwald, JA Miñarro Giménez, RD Boyce… - BMC medical informatics …, 2015 - Springer
Background Every year, hundreds of thousands of patients experience treatment failure or
adverse drug reactions (ADRs), many of which could be prevented by pharmacogenomic …

Genetic polymorphisms of cytochrome P450 enzymes and transport proteins in a Russian population and three ethnic groups of Dagestan

KB Mirzaev, DA Sychev, KA Ryzhikova… - Genetic Testing and …, 2017 - liebertpub.com
Aim: The objective of this study was to investigate the prevalence of polymorphic markers of
the CYP2C19, CYP2C9, CYP2D6, SLCO1B1, and ABCB1 genes among the three ethnic …

Plant antimicrobial peptides as potential tool for topic treatment of hidradenitis suppurativa

CA Santos-Silva, PM Tricarico, LMB Vilela… - Frontiers in …, 2021 - frontiersin.org
Among chronic skin autoinflammatory diseases, Hidradenitis Suppurativa (HS) stands out
for its chronicity, highly variable condition, and profound impact on the patients' quality of life …